Inventor · disambiguated record
John Michael Beals
Also filed as: BEALS JOHN M · BEALS JOHN MICHAEL
9 granted patents·11 pending applications·160 citations·filing 2001–2024
88Inventor score
Top patents by PatentIndex Score
20 records- 0197US10709766B2Fusion proteinsLILLY CO ELI·Filed 2017·Granted Jul 14, 2020·19 cites·13 claims
- 0296US9855318B2Fusion proteinsLILLY CO ELI·Filed 2016·Granted Jan 2, 2018·23 cites·4 claims
- 0394US7491697B2Muteins of fibroblast growth factor 21LILLY CO ELI·Filed 2004·Granted Feb 17, 2009·106 cites·9 claims
- 0492US11253574B2Fusion proteins and methods of useLILLY CO ELI·Filed 2020·Granted Feb 22, 2022·2 cites·3 claims
- 0591US12059452B2Fusion proteinsLILLY CO ELI·Filed 2022·Granted Aug 13, 2024·1 cites·5 claims
- 0688US10035839B2Blood glucose lowering compoundLILLY CO ELI·Filed 2017·Granted Jul 31, 2018·5 cites·6 claims
- 0787US2025032588A1Fusion proteinsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 0866US9050371B2PEGylated insulin lispro compoundsBEALS JOHN MICHAEL·Filed 2009·Granted Jun 9, 2015·3 cites·4 claims
- 0961US2025000950A1Preserved formulationsLILLY CO ELI·Filed 2022·Application pending·0 cites
- 1058US11510967B2Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamolLILLY CO ELI·Filed 2018·Granted Nov 29, 2022·0 cites·11 claims
- 1157US9259479B2Treatment for comorbid diabetes with chronic kidney diseaseLILLY CO ELI·Filed 2013·Granted Feb 16, 2016·1 cites·13 claims
- 1254US2022175891A1Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamolLILLY CO ELI·Filed 2021·Application pending·0 cites
- 1354US2007100133A1Erythropoietic compoundsBEALS JOHN M·Filed 2006·Application pending·0 cites
- 1451US2009118190A1Muteins of fibroblast growth factor 21BEALS JOHN MICHAEL·Filed 2009·Application pending·0 cites
- 1550US2008108560A1Heterologous G-Csf Fusion ProteinsLILLY CO ELI·Filed 2003·Application pending·0 cites
- 1643US2005070692A1Anti-interleukin-1 beta analogsFiled 2003·Application pending·0 cites
- 1742US2004254351A1Hyperglycosylated polypeptidesFiled 2001·Application pending·0 cites
- 1840US2005014679A1Insulin molecule having protracted time actionFiled 2002·Application pending·0 cites
- 1938US2003100502A1Treating musculoskeletal disorders using lp85 and analogs thereofFiled 2001·Application pending·0 cites
- 2034US2015297681A1Pegylated Insulin Lispro CompoundsLILLY CO ELI·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →